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ABSTRACT: Methods for cell-selective analysis of
proteome dynamics will facilitate studies of biological
processes in multicellular organisms. Here we describe a
mutant murine methionyl-tRNA synthetase (designated
L274GMmMetRS) that charges the noncanonical amino
acid azidonorleucine (Anl) to elongator tRNAMet in
hamster (CHO), monkey (COS7), and human (HeLa)
cell lines. Proteins made in cells that express the synthetase
can be labeled with Anl, tagged with dyes or aﬃnity
reagents, and enriched on aﬃnity resin to facilitate
identiﬁcation by mass spectrometry. The method does
not require expression of orthogonal tRNAs or depletion
of canonical amino acids. Successful labeling of proteins
with Anl in several mammalian cell lines demonstrates the
utility of L274GMmMetRS as a tool for cell-selective
analysis of mammalian protein synthesis.
Metabolic labeling of cellular proteins with noncanonicalamino acids (ncAAs) has emerged as an important tool
for the study of proteome dynamics.1−5 Bio-orthogonal
noncanonical amino acid tagging (BONCAT)6 uses metabolic
incorporation of ncAAs into newly made proteins to enable their
enrichment and subsequent identiﬁcation by mass spectrometry.
Newly synthesized proteins can be detected in ﬁxed cells or cell
lysates by [3 + 2]-cycloaddition reactions between the azide side-
chain of an ncAA and alkynyl probes7−9 (Scheme 1a) or tagged
for aﬃnity enrichment and identiﬁed by tandem mass
spectrometry (Scheme 1b). Recent studies have combined
BONCAT with SILAC (stable isotope labeling with amino acids
in cell culture)10 to acquire quantitative information about
protein synthesis in mammalian cell lines11−13 and to identify
secreted proteins in serum-supplemented media.14 These studies
illustrate the utility of the BONCAT method in studies of
proteome dynamics in mammalian cells.
The temporal resolution provided by metabolic labeling
methods can be complemented by cell-selectivity through the
controlled expression of mutant aminoacyl-tRNA synthetases.
Initial studies of this kind were implemented in bacterial
systems15,16 and used to identify proteins injected into
mammalian cells in the course of infection by the bacterial
pathogen Yersinia enterocolitica.17 More recently, cell-selective
methods have been developed for use in Caenorhabditis elegans18
and Drosophila melanogaster.19 Extension of such methods to
mammalian systems represents an attractive challenge.
Our cell-selective studies in bacterial systems used the L13N/
Y260L/H301L mutant form of the E. coli methionyl-tRNA
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Scheme 1. Targeted Expression of Mutant Aminoacyl-tRNA
Synthetases (aaRS) for Cell-Selective BONCAT in
Mammalian Cellsa
a(a) The azide side chain of Anl in proteins (R1) is chemoselectively
tagged through azide−alkyne cycloaddition reactions. (b) Controlled
expression of mutant aaRS in cells of interest restricts labeling to those
cells and enables the detection and identiﬁcation of proteins in a cell-
selective manner. (c) The endogenous mammalian aaRS charges Met
but not Anl. A mutant aaRS is used to charge Anl to tRNAMet.
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synthetase (which we designated NLL-MetRS) to activate the
methionine surrogate L-azidonorleucine (Anl). Because wild-
type MetRS does not activate Anl, BONCAT labeling occurs
only in cells that express the NLL-MetRS. Although one might
imagine using the NLL-MetRS for cell-selective Anl labeling of
mammalian proteins (Scheme 1c), the E. coli enzyme charges
only the initiator tRNA in mammalian cells; it does not charge
elongator tRNAMet,20 and Anl labeling is restricted to N-terminal
positions in mammalian proteins. This observation prompted us
to develop new MetRS variants to tag mammalian cell proteins
with Anl.
We investigated two complementary approaches to cell-
selective incorporation of Anl into mammalian proteins. The ﬁrst
approach aimed to identify mutant mammalian aaRSs that would
charge Anl to endogenous tRNAMet. The second approach
involved coexpression of E. coliNLL-MetRS and E. coli elongator
tRNAMet in mammalian cells. Reports by RajBhandary and co-
workers showing successful concomitant expression of an active
E. coli glutaminyl-tRNA synthetase and a functional amber
suppressor tRNA that is not aminoacylated in vivo by any
mammalian aaRS suggested to us that the mammalian translation
machinery might co-opt an E. coli elongator tRNAMet that is
charged by NLL-MetRS.21,22 To identify mutant mammalian
aaRSs that charge Anl to endogenous tRNAMet, we made a small
mutant aaRS library. We had previously observed that residues
13, 260, and 301 in theMet-binding pocket of E. coliMetRS23 can
be mutated to enable activation of Anl.24 Because there are no
reported structures of mammalian MetRSs, we used sequence
alignment to determine the corresponding positions in the E. coli
and eukaryotic MetRS enzymes (Figure 1a). Conservation of the
residues that align with E. coli residues 13, 260, and 301 suggested
that site-directed mutagenesis at the corresponding positions in
the mouse MetRS (MmMetRS) would yield variants that charge
Anl. Therefore, we constructed a small mutant library in which
residues L274, Y527 and H562 of MmMetRS (“LYH”) were
mutated to SLL, CLL, PLL, and NLL (Figure S1−S6). We also
made an L274G mutant, reﬂecting our earlier observation that
the corresponding L13G variant of the E. coli MetRS activates
Anl.23 Finally, we overexpressed wild-type MmMetRS to
determine whether overexpression of the wild-type enzyme
causes observable levels of incorporation of Anl into cellular
proteins.
MetRS variants were expressed under control of a CMV
promoter (Figure 1b). To express the E. coli elongator tRNAMet,
we adopted the approach of the RajBhandary group and
introduced 5′- and 3′-ﬂanking sequences derived from human
initiator tRNA to enable proper RNA editing21 (Figure 1c).
Notably, eﬃcient transcription by mammalian RNA polymerase
III requires a purine at position 9 of the tRNA coding sequence.
In this case, adenine was used. This adenine lies in the A box of
the internal promoter of eukaryotic tRNA genes.21 In
mammalian cells, the 3′-CCA tail is added by a nucleotidyl-
transferase;25 therefore, we tested tRNA sequences with and
without CCA tails (Figure S7−S9). Wemeasured the activities of
these constructs with respect to Anl incorporation by transiently
transfecting several widely used mammalian cell lines, including
Chinese hamster ovary (CHO) cells, monkey kidney cells
(COS7), and an immortalized human cervical cancer cell line
(HeLa). Cells were incubated in serum-containing medium
supplemented with 1.5 mM Anl for 10 h and then lysed. Total
cellular proteins were treated with alkyne-tetramethylrhodamine
(TAMRA) (Figure S10) for labeling via copper-catalyzed azide−
alkyne cycloaddition (reaction 1, Scheme 1a).7,26,27 After SDS-
PAGE, TAMRA-labeled proteins were detected by in-gel
ﬂuorescence imaging (Figure 1d). As expected, Anl was not
charged to any appreciable extent by the wild-type translational
machinery. Anl incorporation was detected in cells carrying the E.
coli NLL-MetRS, but we did not observe a signiﬁcant increase in
Anl incorporation as a function of tRNA expression. The
variability of incorporation across diﬀerent cell lines suggests that
the expression levels of the tRNA and the synthetase may need to
be optimized for each cell type, thereby limiting the general
applicability of this approach. Nevertheless, variants of this
strategy have already proven useful for cell-selective protein
labeling: for example, Chin and co-workers have described
successful proteome-wide labeling through the action of a
genetically encoded pyrrolysyl-tRNA synthetase/tRNA pair in
Drosophila.28
In contrast to our results with the E. coliNLL-MetRS/tRNAMet
pair, expression of the L274G mouse MetRS, henceforth called
L274GMmMetRS, resulted in robust incorporation of Anl across
all three cell lines. Thus, a single mutation is suﬃcient to enable
Anl incorporation into mammalian cell proteins. Surprisingly, we
found no evidence of signiﬁcant Anl labeling with any of the
triple mutants we examined (Figure 1d).
An important determinant of the utility of a mutant synthetase
in ncAA tagging is the selectivity of the synthetase with respect to
activation of the ncAA and its canonical counterpart. To provide
a practical measure of the selectivity of L274GMmMetRS, we
examined protein labeling in CHO cells as a function of Anl
concentration in serum-containing media. After Anl incorpo-
ration, proteins from cell lysates were labeled with alkyne-
TAMRA (Figure 2a).We also performedMet competition assays
by incubating CHO cells with 1.5 mM Anl in media
supplemented with Met at diﬀerent concentrations (Figure
Figure 1. Identiﬁcation of MetRS variants for metabolic labeling of
mammalian proteins with Anl. (a) Sequence alignment of MetRS
variants with positions 13, 260, and 301 of the E. coliMetRS highlighted.
(b) Constructs for expression of MetRS and E. coli tRNAMet under
control of the CMV promoter and an internal eukaryotic tRNA
promoter, respectively (c) E. coli tRNAMet coding sequence carrying 5′-
and 3′-ﬂanking sequences derived from human initiator tRNAMet. (d)
In-gel ﬂuorescence image shows TAMRA labeling, which indicates Anl
incorporation into cellular proteins. tRNA* carries a 3′-CCA tail in the
tRNA coding sequence. The wild-typemouseMetRS is indicated byWT
and the ±Anl conditions correspond to empty vector labeling controls.
The same gels were stained with colloidal blue dye (Figure S11) for
nonspeciﬁc labeling of all proteins.
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2b). Assuming standard Michaelis−Menten kinetics for
activation of both Met and Anl, we obtained the following
expression (see Figure S12 for derivation):
=
+
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where V is the rate of activation of Anl, KA and KM are the
speciﬁcity constants (kcat/KM)) for Anl and Met, respectively,
and C is a constant. Fitting this equation to the measured
intensities of in-gel TAMRA ﬂuorescence (taken as a measure of
the rate of incorporation of Anl into cellular proteins) yielded a
value of KA/KM of 0.25 (i.e., L274GMmMetRS activates Met 4-
fold faster than Anl at equimolar concentrations of the two
substrates).
The ability to restrict L274GMmMetRS expression to cells of
interest should enable the cell-selective labeling of proteins for
targeted analysis of protein synthesis. To validate this concept,
we developed a reporter construct expressing both
L274GMmMetRS and mCherry under control of a CMV
promoter (pMaRSC). A T2A linker was used to express two
disjointed proteins in the same open reading frame; we reasoned
that fusing L274GMmMetRS and mCherry might alter the
activity of the synthetase and confound protein labeling results
(Figure 3a). As an additional control, we developed a similar
expression construct without mCherry (pMaRS) (Figures S13
and S14). When transfected into CHO cells, both constructs
enabled labeling of cellular proteins at comparable levels,
indicating that L274GMmMetRS was functional in both contexts
(Figures S14 and S15). We used the mCherry signal to track
expression of L274GMmMetRS in pMaRSC-transfected cells.
CHO cells transfected with pMaRSC and incubated with Anl
(1.5 mM, 6 h) were ﬁxed, permeabilized, and treated with alkyne-
TAMRA. We observed TAMRA ﬂuorescence exclusively in the
mCherry-expressing cells, consistent with cell-selective incorpo-
ration of Anl into cellular proteins (Figure 3b).
The CMV promoter drives constitutive expression of
L274GMmMetRS. To enable conditional expression of the
synthetase, we developed a stable CHO cell line containing an
L274GMmMetRS-T2A-mCherry gene under control of a CMV
promoter located just upstream of a loxP-ﬂanked stop sequence
(Figure 3c). These cells were transiently transfected with a
second (activating) construct bearing a strong Ef1α promoter
that drives expression of an eGFP-Cre fusion protein.
We used the eGFP signal to track expression of Cre and
followed the mCherry signal to monitor recombination of the
loxP sites. As expected, in the subset of cells that expressed Cre
(as determined by the GFP signal), we observed both mCherry
expression indicative of loxP recombination and TAMRA
ﬂuorescence from Anl-tagged cellular proteins, conﬁrming that
cell-selective proteomic labeling can be achieved through
regulated transgene expression. These results suggest that
targeted insertion of loxP-L274GMmMetRS cassettes into the
ROSA26 locus of mouse embryonic stem (ES) cells30 should
facilitate engineering of Cre-Lox mice in which tissue-selective
proteomic studies can be performed.
To conﬁrm the utility of L274GMmMetRS as a tool for
proteomic analysis in mammalian systems, we used azadibenzo-
cyclooctyne-functionalized beads to capture (reaction 2, Scheme
1a) and enrich Anl-labeled proteins from lysates of CHO cells
that constitutively express the synthetase under CMV promoter
Figure 2. Selectivity of L274GMmMetRS. In-gel TAMRA ﬂuorescence
and Coomassie staining show Anl incorporation and total protein
content, respectively. Fluorescence values were quantiﬁed and
normalized to total protein levels. (a) Protein labeling in CHO media
using the L274GMmMetRS at diﬀerent Anl concentrations. (b) Protein
labeling using both the L274GMmMetRS at increasing Met
concentrations and 1.5 mM Anl. Plots on the bottom show Anl
incorporation based on quantitated TAMRA ﬂuorescence values. Error
bars indicate standard deviation, and the dotted line represents line of
best ﬁt based on the equation above and was used to calculate selectivity.
Figure 3. Cell-selective proteomic labeling and identiﬁcation. (a)
Design of pMaRSC and pMaRS constructs for the expression of
L274GMmMetRS and a C-terminal Myc-tagged mCherry marker to
track synthetase expression. (b) Fluorescence confocal microscopy
image of CHO cells containing the pMaRSC construct. DAPI shows the
position of cell nuclei. (c) Fluorescence confocal microscopy image of
CHO cells with a LoxP-ﬂanked L274GMmMetRS-T2A-mCherry
sequence transiently transfected with an eGFP-Cre expression vector.
The GFP signal identiﬁes cells that express Cre; the mCherry signal
marks cells in which L274GMmMetRS is expressed. All mCherry+ cells
show TAMRA labeling. The TAMRA andmCherry signal intensities are
linearly correlated (R2 = 0.7), but the mCherry intensity falls below the
threshold for visual detection in some cells. (d) Identiﬁcation of Anl-
labeled proteins by tandem mass spectrometry and annotation in terms
of cellular components using STRAP software.29 Proteins are listed in
Table S1 and discussed more fully in Figure S16.
Journal of the American Chemical Society Communication
DOI: 10.1021/jacs.5b08980
J. Am. Chem. Soc. 2016, 138, 4278−4281
4280
control. After on-resin trypsinization of puriﬁed proteins, we
analyzed the resulting tryptic peptides by tandem mass
spectrometry (Table S1). A total of 996 proteins were identiﬁed
in Anl-treated samples in short (120 min) analyses on a linear
trap quadrupole (LTQ) Orbitrap mass spectrometer. Of these
proteins, 786 were not found in Met-treated controls. Enrich-
ment was conﬁrmed by the acquisition of 19-fold more spectral
counts in analyses of Anl-treated samples as compared to
controls. We detected proteins associated with a wide variety of
cellular components, including nuclear, cytoskeletal, mitochon-
drial, and membrane proteins (Figure 3d, S16). MS analysis of
the proteome of HeLa cells expressing L274GMmMetRS
identiﬁed 161 sites of Anl incorporation, 150 (93%) at internal
Met positions (Figure S18, Table S2). This ratio mirrors the
distribution of Met sites across the proteome.
In summary, we ﬁnd that the L274GMmMetRS functions in a
variety of mammalian cell lines and charges Anl at a rate suﬃcient
for cell-selective proteomic analysis. Surprisingly, the single-site
mutant is superior to all of the triple mutants we evaluated,
including the murine orthologue of the E. coli NLL-MetRS used
previously in cell-selective studies of protein synthesis.15 A
variant of L274GMmMetRS has recently been used for cell-
selective labeling of proteins in Drosophila,19 and we suggest that
targeted expression of this enzyme will provide a broadly useful
approach to proteome and secretome analysis in subpopulations
of mammalian and other eukaryotic cells.
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